<sentence id="0">Defective IL-10-mediated STAT3 phosphorylation in RA CD4+ T cells</sentence>
<sentence id="1">The interaction of IL-10R with IL-10 induces tyrosine phosphorylation and activation of the latent transcription factors STAT1 and STAT3 [ 3 ] .</sentence>
<sentence id="2">Macrophage-specific STAT3-deficient mice demonstrated that STAT3 plays a dominant role in IL-10-mediated anti-inflammatory responses [ 5 ] , which has recently been confirmed in human macrophages by studies of dominant-negative STAT3 overexpression [ 30 ] .</sentence>
<sentence id="3">The induction of STAT1 and STAT3 phosphorylation by IL-10 in PB CD4+ T cells from active RA patients and from healthy controls was examined using western blotting .</sentence>
<sentence id="4">STAT3 phosphorylation was dose-dependently induced after IL-10 activation for 20 min in normal CD4+ T cells ( Fig .</sentence>
<sentence id="5">4a , 4b ) .</sentence>
<sentence id="6">In contrast , STAT3 was phosphorylated in freshly isolated PB CD4+ cells from RA patients and this STAT3 phosphorylation was detectable for up to 6 hours .</sentence>
<sentence id="7">STAT3 phosphorylation was augmented only when activated by as much as 10 ng/ml IL-10 .</sentence>
<sentence id="8">Both sustained STAT3 phosphorylation and defective IL-10-induced STAT3 phosphorylation were found in RA ST CD4+ T cells ( Fig .</sentence>
<sentence id="9">4c ) .</sentence>
<sentence id="10">On the other hand , <scope type="neg" id="0">IL-10-induced STAT1 phosphorylation was <cue type="neg" id="0">not</cue> detected in either RA CD4+ T cells or normal CD4+ T cells ( Fig</scope> .</sentence>
<sentence id="11">4a ) .</sentence>
<sentence id="12">These results <scope type="spec" id="1"> <cue type="spec" id="1">indicate that</cue> STAT3 is the major IL-10-activated STAT in CD4+ T cells , and IL-10-induced STAT3 activation <scope type="spec" id="2"> <cue type="spec" id="2">may</cue> be diminished in active RA , in association with sustained STAT3 phosphorylation</scope></scope> .</sentence>